FDA panel backs first-of-its-kind flu vaccine using mRNA technology

Дата публикации: 18-06-2026 20:11:18

WASHINGTON (AP) — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 pandemic. The Food and Drug Administration is evaluating Moderna's new shot, dubbed mFlusiva, for older [...]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA panel backs first-of-its-kind flu vaccine using mRNA technology	5	7	18-06-2026
2	FDA approves first mRNA-based flu vaccine	0	9.2	06-08-2026
3	FDA approves first mRNA flu vaccine	0	5.78	06-08-2026
4	FDA approves first mRNA flu vaccine	0	5.78	06-08-2026
5	First mRNA-based flu vaccine approved by the FDA for older adults	0	11.83	06-08-2026
6	New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine	0	7.46	06-08-2026
7	First mRNA flu shot gets FDA approval, raising hopes for a more effective vaccine	0	7.35	06-08-2026
8	Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel	0	11.04	18-06-2026
9	FDA Approves mFLUSIVA (influenza vaccine, mRNA) for the Prevention of Seasonal Influenza	0	10.86	05-08-2026
10	First mRNA flu vaccine has been approved for US adults	0	6.79	07-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7. Источник: www.abc27.com.